Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - final report: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 4: Line 4:
|RefDocPart=Glossary - final report
|RefDocPart=Glossary - final report
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00050-Cli-ber ++ TAG-00244-Def-ini ++ TAG-00338-Met-odi ++ TAG-00056-Bio-tik
|RefTagsOriginal=
|RefModule=6
|RefTagsFR=
|RefUnit=6.4.2
}}
}}


Line 14: Line 14:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 6 — Unit 6.4.2
|-
|-
! Scope
! Scope
Line 30: Line 33:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00050-Cli-ber|Clinical study report]], [[Glossary:TAG-00244-Def-ini|Definition]], [[Glossary:TAG-00338-Met-odi|Methodology]], [[Glossary:TAG-00056-Bio-tik|Biostatistics]]
|-
! Tags (original language)
|  
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference WHO WHO - Guidelines for GCP for trials on

pharmaceutical products* 1995

Validity area WHO
Scope(s) HM
Document name WHO - Guidelines for GCP for trials on

pharmaceutical products*

Version / Revision 1995
Status Current
Document type International guideline
Language(s) EN
Description World Health Organization

WHO Technical Report Series, No. 850, 1995, Annex 3 Guidelines for good clinical practice (GCP) for trials on pharmaceutical products*

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 6 — Unit 6.4.2
Scope HM
Document part Glossary - final report
Language EN
Original entry by Florian Adragna
Contributors
Tags Clinical study report, Definition, Methodology, Biostatistics
Comment Definition of final report

Content

final report A comprehensive description of the trial after its completion including a description of experimental methods (including statistical methods) and materials, a presentation and evaluation of the results, statistical analyses and a critical, ethical, statistical and clinical appraisal.